GlobeNewsWire
29 Sept 2026, 11:33 UTC · 1h ago
Verdict
Headline takes no side. We score ELAB +0.60 across two claims — strongly bullish.
+0.60strongly bullish
More positive than 77% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish · 1 new · 1 priced in
PMGC Holdings' subsidiary NorthStrive Biosciences has partnered with Charles River Laboratories to conduct analytical characterization of its EL-22 and EL-32 engineered probiotic programs.
Newpress release dated Sept. 29, 2026
More positive than 67% of claims this week
NorthStrive's probiotic platform, specifically the lead asset EL-22, is being developed to preserve muscle for patients using GLP-1 receptor agonists.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 54% of claims this week
Which stocks this story touches
More positive than 77% of ticker scores this week
The company's subsidiary is advancing its probiotic programs through a new partnership to support clinical development.
More positive than 62% of ticker scores this week
The company secured a new Statement of Work to provide specialized analytical testing services.
More positive than 35% of relationship scores this week
[a_to_b] Charles River Laboratories is providing specialized analytical testing services to PMGC Holdings' subsidiary.
More positive than 35% of relationship scores this week
[a_to_b] PMGC Holdings (through its subsidiary NorthStrive) has contracted Charles River Laboratories to conduct analytical characterization for its probiotic programs.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
5h ago
—
ELAB hasn't traded since this ran. Last close $4.78 (Sep 28); the reaction starts at the next open.
ELAB chart →
